Atherosclerosis | p | [p]b | ||
---|---|---|---|---|
( −) | ( +) | |||
CC-homozygotes | ||||
No. of participants | 452 | 128 | ||
No. of case (%) | 75 (16.6) | 46 (35.9) | ||
Erythrocyte, × 104/μL | 447 ± 40 | 438 ± 41 | 0.023 | |
Model 1 | Ref | 2.13 (1.34, 3.40) | 0.002 | 0.962 |
Model 2 | Ref | 2.15 (1.35, 3.45) | 0.001 | 0.839 |
Model 3 | Ref | 2.25 (1.39, 3.63) | < 0.001 | 0.501 |
Model 4 | Ref | 2.27 (1.41, 3.67) | < 0.001 | 0.240 |
CT-heterozygotes | ||||
No. of participants | 475 | 129 | ||
No. of case (%) | 101 (21.3) | 30 (23.3) | ||
Erythrocyte, × 104/μL | 441 ± 40 | 446 ± 46 | 0.238 | |
Model 1 | Ref | 0.77 (0.47, 1.27) | 0.299 | 0.529 |
Model 2 | Ref | 0.75 (0.46, 1.25) | 0.271 | 0.742 |
Model 3 | Ref | 0.79 (0.47, 1.34) | 0.379 | 0.832 |
Model 4 | Ref | 0.84 (0.50, 1.41) | 0.505 | 0.734 |
TT-homozygotes | ||||
No. of participants | 149 | 41 | ||
No. of case (%) | 26 (17.4) | 7 (17.1) | ||
Erythrocyte, × 104/μL | 441 ± 44 | 450 ± 37 | 0.271 | |
Model 1 | Ref | 0.60 (0.22, 1.63) | 0.320 | 0.433 |
Model 2 | Ref | 0.55 (0.19, 1.58) | 0.269 | 0.299 |
Model 3 | Ref | 0.74 (0.26, 2.16) | 0.586 | 0.321 |
Model 4 | Ref | 0.77 (0.27, 2.15) | 0.614 | 0.090 |